Recent Updates
-
Natural Killer Cell Therapeutics Market Analysis and Forecast, 2022-2032
The global NK cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032
Size, Trending Innovation, Developments Strategy
The growth in the global NK cell therapeutics market is expected to be driven by the rising in the number of clinical trials and the increasing incidence and prevalence of cancer cases.
https://bisresearch.com/industry-report/natural-killer-cell-therapeutics-market.htmlNatural Killer Cell Therapeutics Market Analysis and Forecast, 2022-2032 The global NK cell therapeutics market is expected to reach $5,676.1 million in 2032 from $297.2 million in 2024 at a CAGR of 44.59% during the forecast period 2024-2032 Size, Trending Innovation, Developments Strategy The growth in the global NK cell therapeutics market is expected to be driven by the rising in the number of clinical trials and the increasing incidence and prevalence of cancer cases. https://bisresearch.com/industry-report/natural-killer-cell-therapeutics-market.htmlBISRESEARCH.COMNatural Killer (NK) Cell Therapeutics Market - A Global and Regional Analysis: Focus on NK Cell Therapy Type, Indication, Country, Pipeline Analysis, and Competitive Landscape - Analysis and Forecast, 2022-2032Natural Killer (NK) Cell Therapeutics Market will grow at a CAGR of 44.59% during the forecast by 2032.The report offers latest trends, growth factors, top players, therapeutics, approaches, application, end-user forecast to 2032.Please log in to like, share and comment! -
FLT3 Inhibitors Market Analysis and Forecast, 2022-2032
The global FLT3 inhibitors market is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032.
The global FLT3 inhibitors market growth is expected to be driven by the introduction of novel products, the increasing incidence of acute myeloid leukemia, and the rising research and development investments, among others.
https://bisresearch.com/industry-report/flt3-inhibitors-market.htmlFLT3 Inhibitors Market Analysis and Forecast, 2022-2032 The global FLT3 inhibitors market is expected to reach $2,061.3 million in 2032 from $400.9 million in 2021 at a CAGR of 14.88% during the forecast period 2022-2032. The global FLT3 inhibitors market growth is expected to be driven by the introduction of novel products, the increasing incidence of acute myeloid leukemia, and the rising research and development investments, among others. https://bisresearch.com/industry-report/flt3-inhibitors-market.htmlBISRESEARCH.COMFLT3 Inhibitors Market - A Global and Country Analysis: Focus on Commercialized Therapy, Potential Pipeline Product, and Region - Analysis and Forecast, 2022-2032FLT3 Inhibitors Market to grow at a significant CAGR 14.88%. BIS Research provides deep market insight, industry analysis, trends & Strategies and Implementation that will help your business to grow.0 Comments 0 Shares 525 Views 0 Reviews -
In-orbit Refueling: In-Space Economy & Emerging Growth Opportunities
Wondering how the in-space economy is going to evolve and what will be the significance of in-orbit refueling services in that regard?
BIS Research is organizing an extensive #webinar on "In-Orbit Space Refueling" that will answer all your questions.
The webinar will be hosted by the team of lead research analysts (Aerospace & SpaceTech) at BIS Research, along with our guest presenter Daniel Faber, CEO of Orbit Fab. Learn from the industry leaders about the significance of in-orbit refueling, docking systems, refueling ports, situational awareness, standardization in manufacturing, risks and barriers, and more.
https://bit.ly/3CpLoSG
In-orbit Refueling: In-Space Economy & Emerging Growth Opportunities Wondering how the in-space economy is going to evolve and what will be the significance of in-orbit refueling services in that regard? BIS Research is organizing an extensive #webinar on "In-Orbit Space Refueling" that will answer all your questions. The webinar will be hosted by the team of lead research analysts (Aerospace & SpaceTech) at BIS Research, along with our guest presenter Daniel Faber, CEO of Orbit Fab. Learn from the industry leaders about the significance of in-orbit refueling, docking systems, refueling ports, situational awareness, standardization in manufacturing, risks and barriers, and more. https://bit.ly/3CpLoSG0 Comments 0 Shares 674 Views 0 Reviews -
Narcolepsy Therapeutics Market Analysis and Forecast, 2022-2032
The global narcolepsy therapeutics market is projected to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032.
https://bisresearch.com/industry-report/narcolepsy-therapeutics-market.htmlNarcolepsy Therapeutics Market Analysis and Forecast, 2022-2032 The global narcolepsy therapeutics market is projected to reach $4,912.3 million by 2032 from $915.2 million in 2021 at a CAGR of 15.93% during the forecast period 2022-2032. https://bisresearch.com/industry-report/narcolepsy-therapeutics-market.htmlBISRESEARCH.COMNarcolepsy Therapeutics Market - A Global and Country Level Analysis: Focus on Therapeutics, Indication, Product, and Country - Analysis and Forecast, 2022-2032The global narcolepsy therapeutics market is projected to reach $4,912.3 million by 2032, at a CAGR of 15.93% during 2022-2032. The report offers latest trends, growth factors, top players, indication, regions, therapeutic type.0 Comments 0 Shares 787 Views 0 Reviews -
Spine X-Ray and Computed Tomography (CT) Market - A Global and Regional Analysis
The global spine X-ray and computed tomography market report highlights that the market was valued at $916.0 million in 2020 and is expected to reach $1,623.5 million by the end of 2030. The market is expected to grow at a CAGR of 5.91% during the forecast period 2021-2030.
https://bisresearch.com/industry-report/spine-x-ray-computed-tomography-market.htmlSpine X-Ray and Computed Tomography (CT) Market - A Global and Regional Analysis The global spine X-ray and computed tomography market report highlights that the market was valued at $916.0 million in 2020 and is expected to reach $1,623.5 million by the end of 2030. The market is expected to grow at a CAGR of 5.91% during the forecast period 2021-2030. https://bisresearch.com/industry-report/spine-x-ray-computed-tomography-market.htmlBISRESEARCH.COMSpine X-Ray and Computed Tomography (CT) Market - A Global and Regional Analysis: Focus on Applications, Product, End Users, and Country-Wise Analysis - Analysis and Forecast, 2021-2030Spine X-Ray and Computed Tomography (CT) Market to grow at a significant CAGR 5.91% during 2021-2030. Spine X-Ray and Computed Tomography (CT) Market report by BIS Research provides deep market insight, industry analysis, trends & forecast to 2030 that will help your business to grow.0 Comments 0 Shares 716 Views 0 Reviews -
Axial Spondyloarthritis Market Analysis and Forecast, 2022-2032
The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032.
https://bisresearch.com/industry-report/axial-spondyloarthritis-market.htmlAxial Spondyloarthritis Market Analysis and Forecast, 2022-2032 The global axial spondyloarthritis market was estimated to be at $1,873.8 million in 2021, which is expected to grow with a CAGR of 13.44% and reach $7,937.8 million by 2032. https://bisresearch.com/industry-report/axial-spondyloarthritis-market.htmlBISRESEARCH.COMAxial Spondyloarthritis Market - A Global and Country Analysis: Focus on Commercialized Therapies, Potential Pipeline Products, Indication, and Country - Analysis and Forecast, 2022-2032Axial Spondyloarthritis market is segmented into products, applications, regions. Market is estimated to grow at a significant CAGR of 13.44% by 2032. Axial Spondyloarthritis market report by BIS Research provides deep market insight & country analysis.0 Comments 0 Shares 525 Views 0 Reviews -
Liquid Biopsy Market Trends, Future Growth, Business Outlook, Report 2022 - 2032The global liquid biopsy market is still in the nascent phase. Significant increase in the research and development activities pertaining to next-generation sequencing are underway to develop NGS products and services, which are expected to increase due to the rising number of chronic disease burdens such as cancer. The global liquid biopsy market was estimated to be at...0 Comments 0 Shares 2K Views 0 Reviews
More Stories